Company Filing History:
Years Active: 2021
Title: The Innovations of Dong Hun Woo
Introduction
Dong Hun Woo is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of biotechnology, particularly in the area of tissue fibrosis treatment. His innovative work has the potential to improve the quality of life for many individuals suffering from this condition.
Latest Patents
Dong Hun Woo holds a patent for a recombinant protein aimed at preventing or treating tissue fibrosis. The patent, titled "Recombinant protein for preventing or treating tissue fibrosis and composition for preventing or treating tissue fibrosis comprising the same," describes a protein based on milk fat globule-EGF factor 8 (MFG-E8). This recombinant protein includes the amino acid sequence of SEQ ID NO: 1. The invention demonstrates a significantly improved efficacy in preventing or treating tissue fibrosis compared to conventional MFG-E8 protein. The use of this recombinant protein can restore tissue fibrosis levels to those very close to normal tissue.
Career Highlights
Dong Hun Woo is associated with Nexel Co., Ltd., where he continues to advance his research and development efforts. His work is characterized by a commitment to innovation and a focus on practical applications of his inventions.
Collaborations
He collaborates with notable colleagues, including Choong Seong Han and Gun Sik Cho, who contribute to his research endeavors and help drive forward the mission of their company.
Conclusion
Dong Hun Woo's contributions to the field of biotechnology, particularly through his patented recombinant protein, highlight his role as an influential inventor. His work not only showcases innovation but also holds promise for significant advancements in medical treatments for tissue fibrosis.